Frazier Management as of March 31, 2019
Portfolio Holdings for Frazier Management
Frazier Management holds 17 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 40.7 | $169M | 2.3M | 73.05 | |
| Krystal Biotech (KRYS) | 6.9 | $29M | 875k | 32.90 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 6.9 | $29M | 1.9M | 15.14 | |
| Gritstone Oncology Ord (GRTSQ) | 6.6 | $27M | 2.1M | 13.30 | |
| Allena Pharmaceuticals | 5.6 | $23M | 3.3M | 7.02 | |
| Millendo Therapeutics | 5.0 | $21M | 1.4M | 15.00 | |
| Iovance Biotherapeutics (IOVA) | 5.0 | $21M | 2.2M | 9.51 | |
| Alpine Immune Sciences | 4.2 | $18M | 2.6M | 6.86 | |
| Sierra Oncology | 3.3 | $14M | 8.1M | 1.71 | |
| Aptinyx | 3.1 | $13M | 3.2M | 4.05 | |
| Iterum Therapeutics | 2.9 | $12M | 1.5M | 7.92 | |
| Nabriva Therapeutics | 2.5 | $10M | 4.3M | 2.44 | |
| Entasis Therapeutics Holdings Ord | 2.2 | $9.1M | 1.3M | 6.76 | |
| Synlogic | 1.6 | $6.6M | 865k | 7.59 | |
| Kezar Life Sciences | 1.6 | $6.6M | 370k | 17.74 | |
| Bellicum Pharma | 0.8 | $3.5M | 1.1M | 3.37 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $3.5M | 1.3M | 2.65 |
